Cylindrospermopsin


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000084 Mitotic s phase Increases phenotype PMID:30905859
GO:0000086 G2/m transition of mitotic cell cycle Increases phenotype PMID:30905859
GO:0004602 Glutathione peroxidase activity Increases phenotype PMID:34687773
GO:0004784 Superoxide dismutase activity Increases phenotype PMID:34687773
GO:0006006 Glucose metabolic process Affects phenotype PMID:27494769
GO:0006750 Glutathione biosynthetic process Affects phenotype PMID:30905859
GO:0006915 Apoptotic process Increases phenotype PMID:34687773
GO:0006974 Cellular response to dna damage stimulus Increases phenotype PMID:32244372; PMID:34687773
GO:0007015 Actin filament organization Affects phenotype PMID:34687773
GO:0008219 Cell death Increases phenotype PMID:16020200
GO:0008610 Lipid biosynthetic process Affects phenotype PMID:38735451
GO:0010729 Positive regulation of hydrogen peroxide biosynthetic process Increases phenotype PMID:25863213
GO:0010940 Positive regulation of necrotic cell death Increases phenotype PMID:30500929
GO:0010942 Positive regulation of cell death Increases phenotype PMID:20936652
GO:0032125 Micronucleus organization Increases phenotype PMID:30240729
GO:0034440 Lipid oxidation Increases phenotype PMID:25863213
GO:0043977 Histone h2a-k5 acetylation Increases phenotype PMID:24921660
GO:0044237 Cellular metabolic process Decreases phenotype PMID:32244372; PMID:34687773
GO:0044319 Wound healing, spreading of cells Decreases phenotype PMID:34687773
GO:0044648 Histone h3-k4 dimethylation Increases phenotype PMID:24921660
GO:0045023 G0 to g1 transition Decreases phenotype PMID:30905859
GO:0045930 Negative regulation of mitotic cell cycle Affects phenotype PMID:30905859
GO:0051493 Regulation of cytoskeleton organization Affects phenotype PMID:27494769
GO:0055091 Phospholipid homeostasis Affects phenotype PMID:38735451
GO:0061572 Actin filament bundle organization Affects phenotype PMID:27494769
GO:0070366 Regulation of hepatocyte differentiation Affects phenotype PMID:30500929
GO:0072593 Reactive oxygen species metabolic process Affects phenotype PMID:34687773
GO:0097421 Liver regeneration Affects phenotype PMID:30500929
GO:0140042 Lipid droplet formation Increases phenotype PMID:30500929; PMID:38735451
GO:1901671 Positive regulation of superoxide dismutase activity Decreases phenotype PMID:25863213
GO:1903284 Positive regulation of glutathione peroxidase activity Increases phenotype PMID:25863213
GO:1903428 Positive regulation of reactive oxygen species biosynthetic process Increases phenotype PMID:27494769
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.